Debrief: report what the laboratory knows

Age-specific and method-specific context changed each case. The subtle leukemia concern was CBC-confirmed cytopenias, a low ANC, an immature-cell flag, and smear-confirmed blasts, not a white-count cutoff. The hemoglobin patterns were screen observations shaped by the developmental HbF-to-HbA switch, beta-chain genetics, and transfusion history.

The laboratory can protect a limited specimen in parallel with time-sensitive testing, release verified findings, and communicate, document, and release urgent results as three distinct steps through the approved pathway. Final leukemia classification requires integrated diagnostic workup, and newborn-screen algorithms and confirmatory routes are jurisdictional. Treatment, prognosis, and family counseling remain outside the laboratory's role.

The DxH 900 study interval, manual smear review with a stated 100-cell denominator, local flow-method placeholders, and chemistry values illustrate the reasoning; review current WHO or ICC classification updates, the state newborn-screen algorithm, and local critical-result or specimen-allocation policy, since criteria and thresholds change over time. Communicate the urgent observable finding, preserve the specimen in parallel with testing, document the communication, and release only within the stated boundary.